首页> 外文期刊>Asian spine journal. >Early Detection and Analysis of Children with Multidrug-Resistant Tuberculosis of the Spine
【24h】

Early Detection and Analysis of Children with Multidrug-Resistant Tuberculosis of the Spine

机译:脊柱多药耐药儿童的早期发现与分析

获取原文
           

摘要

Study Design Retrospective case series. Purpose The aim of the study is to report the clinical characteristics, early diagnosis, management, and outcome of children with multidrug-resistant (MDR) tubercular spondylodiscitis and to assess the early detection of rifampicin resistance using the Xpert MTB/ RIF assay. Overview of Literature MDR tuberculosis is on the rise, especially in developing countries. The incidence rate of MDR has been reported as 8.9% in children. Methods A retrospective study of children aged 15 years of age who were diagnosed and treated for MDR tuberculosis of the spine was conducted. Confirmed cases of MDR tuberculosis and patients who had completed at least 18 months of second-line antituberculous treatment (ATT) were included. Children were treated with ATT for 24 months according to drug-susceptibility-test results. Outcome measures included both clinical and radiological measures. Clinical measures included pain, neurological status, and return to school. Radiological measures included kyphosis correction and healing status. Results Six children with a mean age of 10 years were enrolled. The mean follow-up period was 12 months. All the children had previous history of treatment with first-line ATT, with an average of 13.6 months before presentation. Clinically, 50% (3/6 children) had psoas abscesses and 50% had spinal deformities. Radiologically, 50% (three of six children) had multicentric involvement. Three children underwent surgical decompression; two needed posterior stabilization with pedicle screws posteriorly followed by anterior column reconstruction. Early diagnosis of MDR was achieved in 83.3% (five of six children) with Xpert MTB/RIF assay. A total of 83.3% of the children were cured of the disease. Conclusions Xpert MTB/RIF assay confers the advantage of early detection, with initiation of MDR drugs within an average of 10.5 days from presentation. The cost of second-line ATT drugs was 30 times higher than that of first-line ATT.
机译:研究设计回顾案例系列。目的本研究的目的是报告患有多药耐药性(MDR)的结核性脊椎炎的儿童的临床特征,早期诊断,治疗和结果,并评估使用Xpert MTB / RIF分析对利福平耐药的早期检测。文献综述耐多药结核病正在上升,特别是在发展中国家。据报道儿童MDR的发生率为8.9%。方法回顾性分析被诊断为脊柱耐多药结核病的15岁以下儿童。包括确诊的MDR结核病例和完成至少18个月的二线抗结核治疗(ATT)的患者。根据药物敏感性测试结果,对儿童进行了ATT治疗24个月。结果措施包括临床和放射学措施。临床措施包括疼痛,神经系统状况和重返校园。放射学措施包括矫正后凸畸形和恢复状态。结果纳入6名平均年龄为10岁的儿童。平均随访期为12个月。所有的孩子都有一线ATT的治疗史,平均在出院前13.6个月。临床上,50%(3/6名儿童)患有腰肌脓肿,50%患有脊柱畸形。放射学上,有50%(六个孩子中的三个)多中心受累。 3名儿童接受了手术减压。两个需要后方用椎弓根螺钉进行后固定,然后再进行前柱重建。 Xpert MTB / RIF检测可早期诊断MDR,占83.3%(五个孩子中的五个)。共有83.3%的儿童治愈了该病。结论Xpert MTB / RIF分析具有早期发现的优势,在出现后的平均10.5天内即可启动MDR药物。二线ATT药物的价格是一线ATT的30倍。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号